These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 2474209
1. Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs. Ochiai T, Sakamoto K, Gunji Y, Hamaguchi K, Isegawa N, Suzuki T, Shimada H, Hayashi H, Yasumoto A, Asano T. Transplantation; 1989 Aug; 48(2):193-7. PubMed ID: 2474209 [Abstract] [Full Text] [Related]
2. Studies of the effects of FK506 on renal allografting in the beagle dog. Ochiai T, Nagata M, Nakajima K, Suzuki T, Sakamoto K, Enomoto K, Gunji Y, Uematsu T, Goto T, Hori S. Transplantation; 1987 Dec; 44(6):729-33. PubMed ID: 2447688 [Abstract] [Full Text] [Related]
3. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. Ochiai T, Nakajima K, Nagata M, Hori S, Asano T, Isono K. Transplantation; 1987 Dec; 44(6):734-8. PubMed ID: 2447689 [Abstract] [Full Text] [Related]
4. Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Todo S, Demetris AJ, Ueda Y, Imventarza O, Okuda K, Casavilla A, Cemaj S, Ghalab A, Mazzaferro V, Rhoe BS. Transplant Proc; 1987 Oct; 19(5 Suppl 6):57-61. PubMed ID: 2445076 [Abstract] [Full Text] [Related]
7. Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Todo S, Ueda Y, Demetris JA, Imventarza O, Nalesnik M, Venkataramanan R, Makowka L, Starzl TE. Surgery; 1988 Aug; 104(2):239-49. PubMed ID: 2456627 [Abstract] [Full Text] [Related]
8. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial. Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P. Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635 [Abstract] [Full Text] [Related]
11. Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506. Inamura N, Nakahara K, Kino T, Goto T, Aoki H, Yamaguchi I, Kohsaka M, Ochiai T. Transplantation; 1988 Jan; 45(1):206-9. PubMed ID: 2447690 [Abstract] [Full Text] [Related]
15. Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance. Chavin KD, Qin L, Woodward JE, Lin J, Bromberg JS. Transplantation; 1994 Mar 15; 57(5):736-40. PubMed ID: 7511258 [Abstract] [Full Text] [Related]
16. Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine. Hall BM, Tiller DJ, Hardie I, Mahony J, Mathew T, Thatcher G, Miach P, Thomson N, Sheil AG. N Engl J Med; 1988 Jun 09; 318(23):1499-507. PubMed ID: 3285215 [Abstract] [Full Text] [Related]
19. How best to use tacrolimus (FK506) for treatment of steroid- and OKT3-resistant rejection after renal transplantation. Eberhard OK, Kliem V, Oldhafer K, Schlitt HJ, Pichlmayr R, Koch KM, Brunkhorst R. Transplantation; 1996 May 15; 61(9):1345-9. PubMed ID: 8629294 [Abstract] [Full Text] [Related]
20. The immunosuppressive antagonism of low doses of FK506 and cyclosporine. Vathsala A, Goto S, Yoshimura N, Stepkowski S, Chou TC, Kahan BD. Transplantation; 1991 Jul 15; 52(1):121-8. PubMed ID: 1713361 [Abstract] [Full Text] [Related] Page: [Next] [New Search]